BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Consumer Health

Helfgott Institute Gets Funding to Test Mind-Body Practices for Benzodiazepine Reduction

This one-time opportunity is made possible by the US Deprescribing Network, funded by the National Institute on Aging, in support of complementary and...

April 10, 2023 | News

BGI Global's Colorectal Cancer Survey uncovers gaps in awareness and concerns over affordability

This inaugural report seeks to better understand the global state of CRC awareness, as well as attitudes and actions towards CRC screening for average risk...

April 07, 2023 | News

Tuberculosis patients see dramatic cut in treatment duration, treatment effectiveness remains

The TRUNCATE-TB trial recruited 675 people who were diagnosed with pulmonary TB and randomly allocated them to receive the standard treatment for six...

April 06, 2023 | Analysis

Roche Diagnostics India Unveils #BeYourOwnShero Campaign to Educate Women About Cervical Cancer Prevention

Cervical Cancer is India’s second most common cancer, affecting more than 1.23 lakh women each year. Around 77,000 Indian women die of the disease. D...

April 05, 2023 | News

Metabolon Launches Targeted Panels to Study Microbiome and Gut Metabolome in Health and Disease

Metabolon, Inc., the global leader in providing metabolomics solutions that advance a wide variety of research, diagnostic, therapeutic development, and pr...

April 05, 2023 | News

Standigm, Institut Pasteur Korea identify drug candidates for drug-resistant TB with grant

Standigm, a company using artificial intelligence (AI) technology for drug discovery and development, and Korean non profit research institute Instit...

April 05, 2023 | News

Medtronic, DaVita launch Mozarc Medical, aimed at introducing new solutions for patients with kidney failure

Medtronic plc (NYSE: MDT) and DaVita Inc. (NYSE: DVA) today announced the launch of Mozarc Medical—an independent new compan...

April 03, 2023 | News

Verbal Beginnings Partners with The Clinician for Autism Patient Reported Outcomes Program

The program will enable Verbal Beginnings' clients, families, and caregivers to remotely report on the health outcomes that matter most to them, including ...

March 29, 2023 | News

Noul Co. Ltd's The RIGHT Foundation Begins Research and Development to Aid Malaria Control

Noul Co. Ltd (CEO : David Lim) announced that it has signed an agreement with The RIGHT Foundation to conduct a global clinical studies to determine t...

March 28, 2023 | News

World Tuberculosis Day 2023: Innovations and progress in the fight against TB

World Tuberculosis (TB) Day is celebrated every year on March 24th to raise awareness about the global epidemic of TB and the efforts to eliminate the dise...

March 24, 2023 | News

Autism Speaks Pledges to Make World of Difference as Autism Prevalence Rises to 2.7% of Children in U.S.

The Centers for Disease Control and Prevention (CDC) released today its update of autism's estimated prevalence among the nation's children, based on the a...

March 24, 2023 | News

AXA Mind Health Study reveals more than half of Gen Z in Asia are suffering from poor mental health

While the COVID-19 pandemic has taken a heavy toll on mind health across society, the latest findings from the annual AXA Study of Mind Health and Wel...

March 20, 2023 | News

Bolstering Healthcare Quality in Malaysia with Renowned Flagship Hospitals

Malaysia has debuted its first-of-its-kind Flagship Medical Tourism Hospital Programme, announcing the four (4) shortlisted finalists for the programm...

March 17, 2023 | News

Ark Biopharmaceutical and Calibr collaborate on potential first-in-class drug for respiratory diseases

Ark Biopharmaceutical will lead development activities for AK0705 with the goal of initiating clinical studies in 2024. Calibr will continue to collabor...

March 16, 2023 | News

Stay Connected